PF4 and systemic sclerosis: Evidence suggests that there may be increased platelet activity in patients with SSc, due to the underlying vascular damage [10, 11] and many platelet-derived molecules, such as beta-thromboglobulin, thromboxane B2 and platelet factor 4, have been reported to be elevated in patients with SSc [12, 13].